To address the association and impact of the APOA5 −1131T>C polymorphism on clinical parameters of MS, we evaluated the mean values of age, SBP, DBP, WC, FBG, TG, and HDL-C of each genotype and performed multiple regression analysis using the total study population, subjects with MS, and controls. Here, APOA5 is linked to myeloid sarcoma.